EUVIMEDEUVIMED entdecken
MetaanalyseÜbersichtsarbeit

Sarcopenia and Risk of Cardiovascular Events and Mortality: A Meta-analysis of Longitudinal Observational Studies

Ning Wang, Yadan Xiao, Weiya Zhang, Michael Doherty, Yuqing Zhang, Junqing Xie, Hongyi He, Qianlin Weng, Changjun Li, Jie Wei, Chao Zeng, Guanghua Lei und 2 weitere

Canadian Journal of Cardiology · 2026-09 · 42 (9) · 2260-2269

DOI: 10.1016/j.cjca.2026.02.054 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Canadian Journal of Cardiology, 2026-09. Verfasst von Ning Wang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedics, Xiangya Hospital, Central South University, Changsha, China. Hauptthemen laut MEDLINE: Sarcopenia, Cardiovascular Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Hunan Provincial Natural Science Foundation, Education Department of Hunan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The burden of cardiovascular events remains substantial with current care, highlighting the clinical importance of identifying high-risk populations. Sarcopenia, which affects 10%-27% of older adults worldwide, is modifiable but under-recognized in cardiovascular prevention because of unclear risk associations. We aimed to clarify the association between sarcopenia and cardiovascular events risk. METHODS: PubMed, Embase, and Web of Science were searched for longitudinal studies that reported on associations between sarcopenia or its related traits with cardiovascular events risk until January 2024. The primary outcome was a composite of cardiovascular events, encompassing cardiovascular diseases (such as coronary heart disease, heart failure, and stroke) and cardiovascular mortality. Data pooled using random-effects models are presented as risk ratios (RRs) and 95% confidence intervals (CIs). RESULTS: One hundred longitudinal studies (approximately 2.3 million participants) were included. Sarcopenia was associated with higher risk of cardiovascular events (unadjusted RR [uRR] = 1.92; 95% CI, 1.59-2.32; adjusted RR [aRR] = 1.63; 95% CI, 1.30-2.04) and cardiovascular diseases (uRR = 1.69; 95% CI, 1.39-2.04; aRR = 1.28; 95% CI, 1.12-1.46), whereas the association with cardiovascular mortality was significant only in unadjusted analyses (uRR = 2.28; 95% CI, 1.56-3.33; aRR = 1.61; 95% CI, 0.98-2.64). Similar associations with cardiovascular events were observed for low muscle mass (uRR = 1.61; 95% CI, 1.32-1.97; aRR = 1.43; 95% CI, 1.23-1.68) and low grip strength (uRR = 2.04; 95% CI, 1.72-2.44; aRR = 1.46; 95% CI, 1.37-1.56). CONCLUSIONS: Sarcopenia, defined using heterogeneous criteria, was associated with an increased risk of cardiovascular events later in life. These findings suggest that sarcopenia and related traits might serve as markers of elevated subsequent cardiovascular risk. PROSPERO REGISTRATION: CRD42023400266.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SarcopeniaCardiovascular DiseasesHumansLongitudinal StudiesRisk AssessmentRisk FactorsObservational Studies as Topic

Stichwörter der Autor:innen

Cardiovascular diseasemeta-analysismortalitysarcopenia

Autor:innen und Institutionen

  • Department of Orthopaedics, Xiangya Hospital, Central South University, Changsha, China.
  • Department of Epidemiology and Health Statistics, Xiangya School of Public Health, Central South University, Changsha, China.
  • Academic Rheumatology, School of Medicine, University of Nottingham, Nottingham, United Kingdom; Pain Centre Versus Arthritis UK, Nottingham, United Kingdom.
  • Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA; The Mongan Institute, Massachusetts General Hospital, Harvar…
  • Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom.
  • Department of Endocrinology, Endocrinology Research Center, Xiangya Hospital, Central South University, Changsha, China; Hunan Key Laboratory of Joint Degeneration and Injury, Xiangya Hospital, Central South University,…

Förderung

  • National Key Research and Development Program of China
  • Hunan Provincial Natural Science Foundation
  • Education Department of Hunan Province
  • National Natural Science Foundation of China

Zitieren

APA

Wang, N., Xiao, Y., Zhang, W., Doherty, M., Zhang, Y., Xie, J., He, H., Weng, Q., Li, C., Wei, J., Zeng, C., Lei, G., Wang, H., & Wang, Y. (2026). Sarcopenia and Risk of Cardiovascular Events and Mortality: A Meta-analysis of Longitudinal Observational Studies. Canadian Journal of Cardiology, 42(9), 2260-2269. https://doi.org/10.1016/j.cjca.2026.02.054

Vancouver

Wang N, Xiao Y, Zhang W, Doherty M, Zhang Y, Xie J, et al. Sarcopenia and Risk of Cardiovascular Events and Mortality: A Meta-analysis of Longitudinal Observational Studies. Canadian Journal of Cardiology. 2026;42(9):2260-2269. doi:10.1016/j.cjca.2026.02.054

BibTeX
@article{Wang2026,
  author = {Wang, Ning and Xiao, Yadan and Zhang, Weiya and Doherty, Michael and Zhang, Yuqing and Xie, Junqing and He, Hongyi and Weng, Qianlin and Li, Changjun and Wei, Jie and Zeng, Chao and Lei, Guanghua and Wang, Haochen and Wang, Yilun},
  title = {Sarcopenia and Risk of Cardiovascular Events and Mortality: A Meta-analysis of Longitudinal Observational Studies},
  journal = {Canadian Journal of Cardiology},
  year = {2026},
  volume = {42},
  number = {9},
  pages = {2260--2269},
  doi = {10.1016/j.cjca.2026.02.054}
}
Kostenlos starten →